Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Hypertension/High Blood Pressure Health Center

Font Size

Blood Pressure Drugs Linked to Cancer

Angiotensin-Receptor Blockers Raise Risk of Developing Cancer, Research Shows
By Peter Russell
WebMD Health News
Reviewed by Laura J. Martin, MD

June 14, 2010 -- A group of medications commonly used to treat high blood pressure, heart failure, and kidney damage caused by diabetes have been linked to a small increase in the risk of developing cancer, according to a study.

Angiotensin-receptor blockers (ARBs) work by blocking angiotensin II, a hormone that increases blood pressure.

A study published online in The Lancet Oncology states that although there are no major safety concerns associated with ARBs, a previous trial had reported a significantly increased risk of fatal cancers in patients receiving the ARB candesartan compared with a placebo.

Cancer Trials

Researchers from Case Western Reserve University School of Medicine in Cleveland examined data from previous trials of ARBs. They also looked at new cancer data in five trials involving 61,590 patients, common types of cancers (lung, prostate, breast) in another five trials of 68,402 patients, and cancer deaths in eight trials involving 93,515 patients.

Most of the patients in these trials (85.7%) had received the ARB telmisartan.

The researchers report that, overall, those who had taken ARBs had a significantly increased likelihood of new cancer diagnosis compared with patients in comparison groups (7.2% as opposed to 6%).

Among the solid-organ cancers examined, only the risk of lung cancer was significantly increased in patients taking ARBs compared with the comparison groups (0.9% as opposed to 0.7%).

Further Investigation Needed

The researchers say they did not find any evidence of a significant increase in death rates from cancer among those who had taken ARBs, although they caution that the short follow-up period in the trials makes that conclusion hard to judge.

Lead researcher Ilke Sipahi, MD, and colleagues write, “Given the limited data, it is not possible to draw conclusions about the exact risk of cancer associated with each ARB.”

They conclude that “the increased risk of new cancer occurrence is modest but significant. [However] the finding of a 1.2% increase in absolute cancer risk over an average of 4 years needs to be interpreted in view of the estimated 41% background lifetime cancer risk.”

Today on WebMD

blood pressure
Symptoms, causes, and more.
Learn the causes.
Compressed heart
5 habits to change.
Mature man floating in pool, goggles on head
Exercises that help.
heart healthy living
Erectile Dysfunction Slideshow
Bernstein Hypertension Affects Cardiac Risk
Compressed heart
Heart Disease Overview Slideshow
thumbnail for lowering choloesterol slideshow
Heart Foods Slideshow
Low Blood Pressure